T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for crohn's disease-associated bone loss

Journal of Cellular Biochemistry

Volumn 113, Issue 1, 2012, Pages 260-268

  Oostlander, Angela E ^a   Everts, Vincent ^b   Schoenmaker, Ton ^b   Bravenboer, Nathalie ^a   Van Vliet, Sandra J ^a   Van Bodegraven, Ad A ^a   Lips, Paul ^a   De Vries, Teun J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

IL 17; Inflammatory bowel disease; Osteoclastogenesis; Peripheral blood; T cell

Indexed keywords

ACID PHOSPHATASE; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 17; MESALAZINE; OSTEOCLAST DIFFERENTIATION FACTOR; RNA;

ADULT; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; MULTINUCLEAR CELL; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; BONE RESORPTION; CELL PROLIFERATION; CELLS, CULTURED; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-17; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; OSTEOCLASTS; OSTEOPOROSIS; RANK LIGAND; T-LYMPHOCYTES;

EID: 84055218377     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23352     Document Type: Article

References (28)

1. Brunetti G, Colucci S, Pignataro P, Coricciati M, Mori G, Cirulli N, Zallone A, Grassi FR, Grano M,. 2005. T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients. J Periodontol 76: 1675-1680. (Pubitemid 41645576)
2. Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Quarta L, Cirulli N, Mancini L, Corrado A, Grassi FR, Grano M,. 2007. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 212: 47-55. (Pubitemid 46746289)
3. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J,. 1987. Osteoporosis in patients with inflammatory bowel disease. Gut 28: 410-415. (Pubitemid 17056874)
4. Coury F, Annels N, Rivollier A, Olsson S, Santoro A, Speziani C, Azocar O, Flacher M, Djebali S, Tebib J, Brytting M, Egeler RM, Rabourdin-Combe C, Henter JI, Arico M, Delprat C,. 2008. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14: 81-87.
5. D'Amelio P, Grimaldi A, Pescarmona GP, Tamone C, Roato I, Isaia G,. 2005. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. FASEB J 19: 410-412. (Pubitemid 40316533)
6. D'Amelio P, Grimaldi A, Di Bella S, Brianza SZ, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D, Pescarmona GP, Isaia G,. 2008. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis. Bone 43: 92-100.
7. de Vries TJ, Everts V,. 2009. Osteoclast formation from peripheral blood of patients with bone-lytic diseases. Clinic Rev Bone Miner Metab 7: 285-292.
8. Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S,. 2010. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 30: 80-89.
9. Elsasser-Beile U, von Kleist S, Gerlach S, Gallati H, Mönting JS,. 1994. Cytokine production in whole blood cell cultures of patients with Crohn's disease and ulcerative colitis. J Clin Lab Anal 8: 447-451. (Pubitemid 24376810)
10. Harada H, Kukita T, Kukita A, Iwamoto Y, Iijima T,. 1998. Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: A possible role in direct interaction between osteoclast precursors. Endocrinology 139: 3967-3975. (Pubitemid 28512280)
11. Kazazi F, Chang J, Lopez A, Vadas M, Cunningham AL,. 1994. Interleukin 4 and human immunodeficiency virus stimulate LFA-1-ICAM-1-mediated aggregation of monocytes and subsequent giant cell formation. J Gen Virol 75 (Pt 10): 2795-2802. (Pubitemid 24303199)
12. Kurachi T, Morita I, Murota S,. 1993. Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development. Biochim Biophys Acta 1178: 259-266. (Pubitemid 23276218)
13. Lennard-Jones JE,. 1989. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170: 2-6. (Pubitemid 20015811)
14. Liu ZJ, Yadav PK, Su JL, Wang JS, Fei K,. 2009. Potential role of Th17cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 15: 5784-5788.
15. Marlin SD, Springer TA,. 1987. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51: 813-819.
16. Mazlam MZ, Hodgson HJ,. 1992. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 33: 773-778.
17. Miranda-Carús ME, Benito-Miguel M, Balsa A, Cobo- Ibáñez T, Pérez deAyala C, Pascual-Salcedo D, Martin-Mola E,. 2006. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum 54: 1151-1164. (Pubitemid 43672928)
18. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S,. 1992. Cytokine production in patients with inflammatory bowel disease. Gut 33: 933-937.
19. Nose M, Yamazaki H, Hagino H, Morio Y, Hayashi S, Teshima R,. 2009. Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients. J Bone Miner Metab 27: 57-65.
20. Olivier B, Schoenmaker T, Mebius RE, Everts V, Mulder CJ, van Nieuwkerk KM, de Vries TJ, van der Merwe SW,. 2008. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia. Hepatology 47: 259-267. (Pubitemid 351171063)
21. Oostlander AE, Bravenboer N, Sohl E, Holzmann PJ, van der Woude CJ, Dijkstra G, Stokkers PC, Oldenburg B, Netelenbos JC, Hommes DW, van Bodegraven AA, Lips P,. 2011. Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease. Gastroenterology 140: 116-123.
22. Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B,. 1996. Increased production of tumour necrosis factor-alpha interleukin-1 beta and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 39: 684-689. (Pubitemid 26426469)
23. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM,. 2003. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111: 821-831. (Pubitemid 37074957)
24. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H,. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203: 2673-2682. (Pubitemid 44833343)
25. Schulte CM,. 2004. Review article: Bone disease in inflammatory bowel disease. Aliment Pharmacol Ther 20 (Suppl. 4): 43-49. (Pubitemid 39319246)
26. Tjoa ST, de Vries TJ, Schoenmaker T, Kelder A, Loos BG, Everts V,. 2008. Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor. J Clin Periodontol 35: 568-575.
27. 2+ modulates leukocyte function-associated antigen-1 cell surface distribution on T lymphocytes and consequently affects cell adhesion. J Cell Biol 124: 1061-1070.
28. Yago T, Nanke Y, Ichikawa N, Kobashigawa T, Mogi M, Kamatani N, Kotake S,. 2009. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: A novel mechanism of osteoclastogenesis by IL-17. J Cell Biochem 108: 947-955.